An international team of scientists has found that a lactation drug could reduce the risk of breast cancer in mothers after ...

A form of lung cancer, which is found in about 10%–15% of Western patients and 40%–50% of Asian patients, is driven by a ...

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.

Wall Street analysts believe Verastem’s drug to now be “competitive” in what’s quickly become one of the most active and ...

Verastem plans to raise $250 million as it prepares for late-stage testing of its experimental cancer treatment.

CDK4/6 inhibitors — possible colitis: Ibrance, Kisqali (including the Kisqali Femara Co-Pack) and Verzenio. These pills are ...

Thyme Care, the nationally recognized oncology company, and Texas Oncology, the nation's leading cancer care organization, today announced new data showing that weight-based dosing of pembrolizumab, ...

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Anktiva’s newfound FDA label expansion comes as the agency deems cases of CIS and high-grade papillary only NMIBC clinically similar.

A Phase 3 trial of firmonertinib did not meet its main goal in a hard-to-treat lung cancer subtype, though the drug caused ...

BioNTech's cancer pipeline is bigger than its COVID-era reputation suggests, and the stock still trades below $100.

Uganda Cancer Institute (UCI) has partnered with American pharmaceutical and biotechnology company Pfizer to improve access ...